These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Enhanced lung toxicity of butylated hydroxytoluene in mice by coadministration of butylated hydroxyanisole.
    Author: Yamamoto K, Tajima K, Okino N, Mizutani T.
    Journal: Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):219-31. PubMed ID: 3358012.
    Abstract:
    The ip coadministration of 200 mg/kg butylated hydroxyanisole (BHA) with a subtoxic dose (200 mg/kg) of butylated hydroxytoluene (BHT) enhanced the lung toxicity of BHT in mice. BHA coadministration significantly increased the radioactivity covalently bound to lung macromolecules at 4-8 hr after [14C]BHT. The area under the concentration versus time curve (AUC) for unchanged BHT in the lung for 24 hr after the coadministration was about 140% of that after the sole administration of BHT. At 2-8 hr after BHT, the coadministration produced a 40-85% increase in plasma concentration of unchanged BHT, but a 40-60% decrease in plasma concentration of total BHT (mainly consisted of BHT metabolites). The total metabolism of BHT by liver 9000 g supernatant was significantly reduced by in vitro addition of BHA. Pretreatment of mice with 200 mg/kg BHA also reduced the rate of 9000 g supernatant metabolism of BHT. These results support the suggestion that coadministration of BHA and BHT results in a decrease in the first-pass metabolism of BHT in the liver and thus the lung is exposed to a larger amount of BHT, developing enhanced toxic response.
    [Abstract] [Full Text] [Related] [New Search]